DXR.O (DXR.O) News
Follow DXR.O (DXR.O) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 3 public stories across 3 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Daxor Showcases Blood Volume Analyzer at MedAxiom CV Transforum
Daxor will attend MedAxiom's CV Transforum Fall '26 in Denver, Colorado, October 22-24, 2026. Commercial leaders will demonstrate the FDA-cleared next-generation Blood Volume Analyzer platform to cardiovascular executive
REGULATION | Oct 15, 2026, 01:29 PM UTC
L
Daxor says HFSA study shows blood volume analysis improves diuresis in mechanical pump heart failure patients
Daxor reported new clinical study results already presented at HFSA 2026, alongside signs of rising clinician interest in its BVA diagnostic system. Data in high-acuity heart failure patients suggested direct blood-volum
NEWS | Oct 14, 2026, 12:07 PM UTC
L
Daxor to exhibit Blood Volume Analysis platform at ASN Kidney Week 2026
Daxor will exhibit at ASN Kidney Week 2026 at the Colorado Convention Center in Denver, Colorado, Oct. 21-25, 2026. Showcase will focus on its Blood Volume Analysis platform, targeting fluid management in complex kidney
NEWS | Oct 13, 2026, 12:06 PM UTC